BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2012
View Archived Issues
New Pfizer product shows promising anticancer actvity
Read More
Genentech presents PK/PD model for IBD therapy
Read More
Companies seek approval in Japan for biosimilar of filgrastim
Read More
New promising results disclosed on brodalumab in plaque psoriasis
Read More
New technology launched by arGEN-X
Read More
Xention discloses encouraging phase I data on candidate AF drug
Read More
Shire exercises option to license candidate agent for CNS disorders
Read More
Scientists identify new potential biomarker of myxoid/round cell liposarcoma
Read More
Halo Therapeutics reports on independent review of lead product
Read More
PROLOR Biotech launches pediatric trial of long-acting human growth hormone
Read More
Proteonomix announces completion of private placement
Read More
Patrys reports on phase I PAT-SM6 trial
Read More
Taisho reports novel sodium/glucose cotransporter 1 inhibitors
Read More
New candidate pain therapies designed at Gruenenthal
Read More
Novel inhibitors of MPGES-1 developed
Read More
Cedars-Sinai Medical Center presents new potential atherosclerosis therapies
Read More
Karo Bio scientists discover new ER-beta ligands
Read More
Aerpio discloses phase I data on agent for diabetic macular edema
Read More
EMA accepts lomitapide MAA for review
Read More
First patient enrolled in phase I/II study of PET imaging agent for brain cancer
Read More
Milestone reached in OncoTherapy Science/Shionogi collaboration
Read More
Taiho and Nordic Group launch Teysuno
Read More
Telotristat etiprate receives FDA orphan drug status
Read More
FDA's ODAC votes regarding approval of ridaforolimus
Read More
GSK gives update on FDA's ODAC review of Votrient
Read More